Streetbeat News

Earnings

SMLP

Summit Midstream Partners (NYSE:SMLP) reported Q3 losses of $(0.27) per share, a 78.91% increase YoY. The company's quarterly sales were $121.19 million, beating the analyst consensus estimate of $98.10 million by 23.54% and marking a 36.66% increase YoY.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 11:13 am

SHEN

Shenandoah (NASDAQ:SHEN) reported Q3 earnings of $0.03 per share, beating the analyst consensus estimate of $(0.01) by 400 percent. This is a 160 percent increase over losses of $(0.05) per share from the same period last year. The company also reported quarterly sales of $71.84 million, beating the analyst consensus estimate of $71.18 million by 0.93 percent, a 7.35 percent increase over sales of $66.92 million the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 11:10 am

MORF

Morphic Holding reported Q3 losses of $(0.73) per share, beating the analyst consensus estimate of $(0.95) by 23.16%. This is a 6.41% increase over losses from the same period last year. The company ended Q3 with $725.1M in cash, cash equivalents, and marketable securities, providing a runway into the second half of 2027.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 11:09 am

LOVE

Lovesac has projected its Q3 revenue to be $154M, slightly higher than the estimated $153.35M. However, the company expects its EPS to be between $(0.20) and $(0.33), significantly lower than the estimated $0.03.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 11:09 am

CHD

Church & Dwight Company has reiterated its FY23 adjusted EPS outlook of $3.15, which represents a 6% YoY increase. This is slightly below the $3.16 estimate. The company also raised its gross margin expansion forecast to +210 bps from +200 bps.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 11:09 am

LOVE

Lovesac has projected its FY24 earnings per share (EPS) to be between $1.21 and $1.75, which is lower than the estimated $1.93.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 11:07 am

ACIU

AC Immune (NASDAQ:ACIU) reported a 20% increase in its quarterly losses, with an EPS of $(0.20), compared to $(0.17) in the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 11:07 am

LOVE

Lovesac (NASDAQ:LOVE) reported Q2 earnings per share of $(0.04), beating the analyst consensus estimate of $(0.13) by 69.23%. This is a 108.89% decrease from the same period last year. The company also reported quarterly sales of $154.50 million, beating the analyst consensus estimate of $150.66 million by 2.55%. This is a 4.02% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 11:04 am

SRE

Sempra Energy has updated its FY23 GAAP EPS guidance to $4.44 to $4.74, and expects to be at or above the high-end adjusted EPS guidance of $4.30 to $4.60, compared to the consensus of $4.5. The company also affirmed its full-year 2024 EPS guidance range of $4.55 to $4.90 and its projected long-term EPS growth rate of 6% to 8%.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 11:04 am

ONCY

Oncolytics Biotech reported a wider loss in Q3 with an EPS of $(0.10).

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 11:04 am